Annual Drug Patent Expirations for IBSRELA
Ibsrela is a drug marketed by Ardelyx Inc and is included in one NDA. There are four patents protecting this drug.
This drug has thirty-one patent family members in twenty-one countries.
The generic ingredient in IBSRELA is tenapanor hydrochloride. Additional details are available on the tenapanor hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com